Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Functional Characterization of Retinal Degeneration in a Mouse Model of Mucopolysaccharidosis Type IIIC.

Created on 17 Nov 2026

Authors

Christos Iosifidis, Shaun Wood, Lisa Mckie, Chia Shyan Beh, Roly Megaw, Graeme Black, Brian Bigger

Published in

Investigative ophthalmology & visual science. Volume 67. Issue 13. Pages 31. Nov 02, 2026.

Abstract

Mucopolysaccharidosis type IIIC (MPSIIIC) is a lysosomal storage disorder caused by HGSNAT deficiency, leading to heparan sulfate accumulation and progressive neurodegeneration. Although retinal degeneration has been described in patients with MPSIIIC, the onset and progression of ocular disease remain poorly characterized. The purpose of this study is to functionally characterize the natural history of retinal disease in an animal model of MPSIIIC.
The retinal structure in Hgsnat-/- mice and age-matched C57BL/6J controls was assessed at 2, 4, and 6 months of age using spectral-domain optical coherence tomography (SD-OCT). Electroretinography (ERG) was performed at 3, 6, and 8 months of age to assess retinal function. Retinal cryosections were stained for retinal markers to evaluate histopathologic changes. HGSNAT enzymatic activity was measured in dissected ocular tissue using a fluorometric substrate assay.
Enzymatic assays confirmed significantly reduced HGSNAT activity in ocular tissues of Hgsnat-/- mice compared with C57BL/6J controls. Photoreceptor degeneration was evident in Hgsnat-/- mice from 2 months of age and progressed over time. SD-OCT revealed progressive thinning of the outer retina, with degeneration of the outer nuclear layer and ellipsoid zone. ERG recordings confirmed late-stage reductions in photoreceptor function.
Hgsnat-/- mice develop a progressive, early-onset retinal degeneration that predominantly affects the outer retina. These findings closely mirror clinical features of HGSNAT-associated retinal dystrophy and establish this model as a valuable platform for mechanistic studies and preclinical therapeutic development targeting retinal involvement.

PMID:
43043344
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement